Welcome to GreenLeaf Research

 

Visionaries Wanted

 
 
 
 
 
 
 
 
 

Our Mission

GreenLeaf Research’s (GLR) mission is to provide a collaborative research platform dedicated to generating comprehensive and scientifically relevant data to support the safe, effective, and therapeutic use of cannabis.

Our Team

GLR's scientific and leadership teams are lead by researchers and business professionals with decades of experience in academic, industry and government institutions within the biomedical research community.

Our Science

Our scientific work demonstrates the importance of dose, even from full-spectrum hemp extracts, in CBD’s anxiolytic properties and they shed light on the role of terpenes and minor cannabinoids in these anxiolytic effects.

Latest From Our News

The increased legalization of cannabis worldwide has driven a corresponding growth in research and development.
Scientists have found in a small study that 89 percent of dogs who received CBD in the clinical trial had a reduction in the frequency of seizures. Nine dogs were treated with CBD, while seven in a control group were treated with a placebo.
CBD stands for cannabidiol. It is the second most prevalent of the active ingredients of cannabis (marijuana). While CBD is an essential component of medical marijuana, it is derived directly from the hemp plant

Latest From Our Events